Select Medical (SEM) Rating Lowered to Sell at Zacks Investment Research

Select Medical (NYSE:SEM) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a research note issued on Thursday.

According to Zacks, “Select Medical Holdings Corporation, through its subsidiaries, operates specialty hospitals and outpatient rehabilitation clinics. The company’s Specialty Hospital segment offers long-term acute care hospital services and inpatient acute rehabilitative hospital care services. Its Outpatient Rehabilitation segment operates clinics and provides physical, occupational, and speech rehabilitation services. The company also provides medical rehabilitation services on a contract basis to nursing homes, hospitals, assisted living and senior care centers, schools, and work sites. The Mission of Select Medical Corporation is to ensure high-quality health care and cost-effective outcomes by providing specialty inpatient long-term acute care and rehabilitation, and outpatient rehabilitation services. The company is headquartered in Mechanicsburg, Pennsylvania. “

Several other research firms have also recently issued reports on SEM. ValuEngine cut Select Medical from a “buy” rating to a “hold” rating in a report on Monday, October 2nd. Robert W. Baird set a $25.00 price objective on Select Medical and gave the stock a “buy” rating in a report on Monday, October 23rd. Royal Bank of Canada reiterated a “buy” rating and issued a $19.00 price objective on shares of Select Medical in a report on Friday, October 13th. Deutsche Bank reiterated a “buy” rating and issued a $22.00 price objective on shares of Select Medical in a report on Monday, November 6th. Finally, Bank of America upgraded Select Medical from an “underperform” rating to a “neutral” rating and set a $19.00 price objective on the stock in a report on Thursday, January 4th. Two research analysts have rated the stock with a sell rating, three have given a hold rating and five have assigned a buy rating to the company. The company currently has an average rating of “Hold” and a consensus price target of $19.43.

Shares of Select Medical (NYSE SEM) opened at $17.25 on Thursday. Select Medical has a 12-month low of $12.00 and a 12-month high of $19.77. The company has a debt-to-equity ratio of 3.36, a quick ratio of 1.51 and a current ratio of 1.51. The company has a market capitalization of $2,288.41, a PE ratio of 23.63, a PEG ratio of 1.09 and a beta of 1.34.

Select Medical (NYSE:SEM) last posted its quarterly earnings data on Thursday, November 2nd. The health services provider reported $0.14 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $0.16 by ($0.02). Select Medical had a return on equity of 11.44% and a net margin of 2.21%. The firm had revenue of $1.10 billion during the quarter, compared to analyst estimates of $1.10 billion. During the same quarter in the previous year, the firm posted $0.06 earnings per share. The company’s quarterly revenue was up 4.1% on a year-over-year basis. analysts predict that Select Medical will post 0.86 earnings per share for the current fiscal year.

In other Select Medical news, insider Martin F. Jackson sold 156,603 shares of the firm’s stock in a transaction that occurred on Wednesday, December 13th. The shares were sold at an average price of $17.06, for a total value of $2,671,647.18. Following the transaction, the insider now directly owns 1,790,601 shares of the company’s stock, valued at approximately $30,547,653.06. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Michael E. Tarvin sold 18,500 shares of the firm’s stock in a transaction that occurred on Monday, October 30th. The stock was sold at an average price of $18.97, for a total transaction of $350,945.00. Following the completion of the transaction, the insider now directly owns 340,044 shares in the company, valued at $6,450,634.68. The disclosure for this sale can be found here. Insiders sold a total of 314,455 shares of company stock worth $5,403,144 over the last three months. Corporate insiders own 19.93% of the company’s stock.

A number of institutional investors and hedge funds have recently added to or reduced their stakes in SEM. Orbimed Advisors LLC lifted its stake in Select Medical by 51.3% in the 3rd quarter. Orbimed Advisors LLC now owns 5,578,500 shares of the health services provider’s stock worth $107,107,000 after purchasing an additional 1,891,100 shares in the last quarter. Point72 Asset Management L.P. purchased a new position in Select Medical in the 3rd quarter worth approximately $20,751,000. Hood River Capital Management LLC purchased a new position in Select Medical in the 3rd quarter worth approximately $19,840,000. Vanguard Group Inc. lifted its stake in Select Medical by 3.9% in the 2nd quarter. Vanguard Group Inc. now owns 9,929,821 shares of the health services provider’s stock worth $152,423,000 after purchasing an additional 369,044 shares in the last quarter. Finally, Voya Investment Management LLC lifted its stake in Select Medical by 24.5% in the 2nd quarter. Voya Investment Management LLC now owns 1,850,668 shares of the health services provider’s stock worth $28,407,000 after purchasing an additional 364,721 shares in the last quarter. 77.90% of the stock is currently owned by institutional investors and hedge funds.

COPYRIGHT VIOLATION NOTICE: “Select Medical (SEM) Rating Lowered to Sell at Zacks Investment Research” was reported by BBNS and is owned by of BBNS. If you are viewing this piece of content on another publication, it was stolen and republished in violation of international trademark & copyright legislation. The legal version of this piece of content can be read at https://baseballnewssource.com/markets/select-medical-sem-rating-lowered-to-sell-at-zacks-investment-research/1870434.html.

Select Medical Company Profile

Select Medical Holdings Corporation is an operator of specialty hospitals, outpatient rehabilitation clinics and occupational medicine centers in the United States. The Company’s segments include specialty hospitals, outpatient rehabilitation, Concentra and Other. The specialty hospitals segment consists of hospitals designed to serve the needs of long term acute patients and hospitals designed to serve patients that require intensive medical rehabilitation care.

Get a free copy of the Zacks research report on Select Medical (SEM)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Analyst Recommendations for Select Medical (NYSE:SEM)

Receive News & Ratings for Select Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Select Medical and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Red Sox: J.D. Martinez Continues His Physical at Spring Training Facility
Red Sox: J.D. Martinez Continues His Physical at Spring Training Facility
Three-Way Trade Sends Souza to Diamondbacks and Drury to Yankees
Three-Way Trade Sends Souza to Diamondbacks and Drury to Yankees
Eric Hosmer Agrees to Eight-Year Deal with San Diego Padres
Eric Hosmer Agrees to Eight-Year Deal with San Diego Padres
Report: Eduardo Nunez and Red Sox Agree to Deal for One Year
Report: Eduardo Nunez and Red Sox Agree to Deal for One Year
Los Angeles Angels Plan to Use Shohei Ohtani in Six-Man Rotation
Los Angeles Angels Plan to Use Shohei Ohtani in Six-Man Rotation
Cubs Sign Free Agent Yu Darvish
Cubs Sign Free Agent Yu Darvish


Leave a Reply

 
© 2006-2018 BBNS.